++
For further information, see CMDT Part 21-02: Hyponatremia
+++
Essentials of Diagnosis
++
Euvolemic hypotonic hyponatremia, particularly among hospitalized patients
Serum sodium concentration < 135 mEq/L (< 135 mmol/L)
Plasma osmolality < 280 mOsm/kg and UNa > 20 mEq/L
Risk of osmotic demyelination syndrome from overly rapid correction of serum sodium
+++
General Considerations
++
ADH is secreted in the absence of an appropriate physiologic stimuli (eg. hypovolemia or hyperosmolality)
There is failure to suppress ADH action; water is inappropriately retained leading to relatively concentrated urine
SIADH is a diagnosis of exclusion; must rule out other causes of hyponatremia (eg, hypovolemia, decreased solute intake, cortisol deficiency, and severe hypothyroidism)
Major causes of SIADH are disorders affecting the CNS, lungs (eg. cancer or infection) and medications (Table 21–2)
++
++
Frequently asymptomatic; symptoms depend on severity and acuity of the hyponatremia
Acute hyponatremia (present for < 48 hours)
Symptoms mainly relate to brain cell swelling and rise in intracranial pressure: headache, inattentiveness, lethargy, disorientation, and nausea
Most serious symptoms: marked confusion, decreased level of consciousness, vomiting, seizures, coma, brainstem herniation, death
Chronic hyponatremia (present for > 48 hours)
+++
Differential Diagnosis
++
++
SIADH is a clinical diagnosis in a euvolemic patient
Characterized by
Hypotonic hyponatremia (Figure 21–1)
Decreased plasma osmolality (< 280 mOsm/kg)
UNa > 20 mEq/L, urine osm > 100 mOsm/kg
Absence of heart, kidney, or liver disease
Normal thyroid and adrenal function
In clinical practice, ADH levels are not measured; urine osmolality is a surrogate for ADH activity
Low blood urea nitrogen (BUN) (< 5–10 mg/dL) and hypouricemia (< 4 mg/dL)
++